GGrantIndex
← Leaderboards

Lei Wang

Henry Ford Health System

$4,580,286
Attributed
$4,580,286
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $643.5K · FY201223
$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$4,580,286 · 4

By mechanism

R01$4,204,036 · 3
R56$376,250 · 1

Top collaborators

No co-investigators on record.

Most similar at Henry Ford Health System

Same institution · by research overlap

Others in their field

Top investigators on “Molecular

Research focus

MolecularAmericanAffectTherapeutic EffectMediatingComplications Of Diabetes MellitusNeuronsNeurologic DysfunctionsSchwann CellsSpinal GangliaDiabeticPeripheral Nervous System DiseasesDesignPeripheral NervesDiabetic MouseDisabilityNeurological OutcomeNervous System PhysiologyDiabetes MellitusBaseAxonNon-Insulin-Dependent Diabetes MellitusEffective TherapyDb/Db Mouse

Grant awards (13)

Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic mice$411,157
R01 · FY2023 · DK · contact PI
Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic mice$411,157
R01 · FY2022 · DK · contact PI
Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic mice$411,157
R01 · FY2021 · DK · contact PI
Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic mice$411,157
R01 · FY2020 · DK · contact PI
Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic mice$376,250
R56 · FY2018 · DK · contact PI
Thymosin Beta4 Promotes the Recovery of Peripheral neuropathy in Type II Diabetic$322,988
R01 · FY2016 · DK · contact PI
Thymosin Beta4 Promotes the Recovery of Peripheral neuropathy in Type II Diabetic$322,988
R01 · FY2015 · DK · contact PI
PDE5 is a Therapeutic Target for Peripheral Neuropathy in Diabetic Mice$320,469
R01 · FY2015 · NS · contact PI
Thymosin Beta4 Promotes the Recovery of Peripheral neuropathy in Type II Diabetic$322,988
R01 · FY2014 · DK · contact PI
PDE5 is a Therapeutic Target for Peripheral Neuropathy in Diabetic Mice$317,265
R01 · FY2014 · NS · contact PI
Thymosin Beta 4 Promotes Recovery of Peripheral Neuropathy in Diabetic Mice$322,988
R01 · FY2013 · DK · contact PI
PDE5 is a Therapeutic Target for Peripheral Neuropathy in Diabetic Mice$309,253
R01 · FY2013 · NS · contact PI
PDE5 is a Therapeutic Target for Peripheral Neuropathy in Diabetic Mice$320,469
R01 · FY2012 · NS · contact PI